Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

Striatal CB1 and D2 receptors regulate expression of each other, CRIP1A and δ opioid systems.

Blume LC, Bass CE, Childers SR, Dalton GD, Roberts DC, Richardson JM, Xiao R, Selley DE, Howlett AC.

J Neurochem. 2013 Mar;124(6):808-20. doi: 10.1111/jnc.12139. Epub 2013 Jan 31.

2.

Cannabinoid receptor interacting protein suppresses agonist-driven CB1 receptor internalization and regulates receptor replenishment in an agonist-biased manner.

Blume LC, Leone-Kabler S, Luessen DJ, Marrs GS, Lyons E, Bass CE, Chen R, Selley DE, Howlett AC.

J Neurochem. 2016 Nov;139(3):396-407. doi: 10.1111/jnc.13767. Epub 2016 Sep 26.

PMID:
27513693
3.

Cannabinoid receptor-interacting protein 1a modulates CB1 receptor signaling and regulation.

Smith TH, Blume LC, Straiker A, Cox JO, David BG, McVoy JR, Sayers KW, Poklis JL, Abdullah RA, Egertová M, Chen CK, Mackie K, Elphick MR, Howlett AC, Selley DE.

Mol Pharmacol. 2015 Apr;87(4):747-65. doi: 10.1124/mol.114.096495. Epub 2015 Feb 5.

4.

Expression and function of CB1 receptor in the rat striatum: localization and effects on D1 and D2 dopamine receptor-mediated motor behaviors.

Martín AB, Fernandez-Espejo E, Ferrer B, Gorriti MA, Bilbao A, Navarro M, Rodriguez de Fonseca F, Moratalla R.

Neuropsychopharmacology. 2008 Jun;33(7):1667-79. Epub 2007 Oct 24.

5.
7.

Antagonism of Dopamine Receptor 2 Long Affects Cannabinoid Receptor 1 Signaling in a Cell Culture Model of Striatal Medium Spiny Projection Neurons.

Bagher AM, Laprairie RB, Kelly ME, Denovan-Wright EM.

Mol Pharmacol. 2016 Jun;89(6):652-66. doi: 10.1124/mol.116.103465. Epub 2016 Apr 6.

8.

Cannabinoid receptor interacting protein (CRIP1a) attenuates CB1R signaling in neuronal cells.

Blume LC, Eldeeb K, Bass CE, Selley DE, Howlett AC.

Cell Signal. 2015 Mar;27(3):716-726. doi: 10.1016/j.cellsig.2014.11.006. Epub 2014 Nov 17.

9.

CRIP1a inhibits endocytosis of G-protein coupled receptors activated by endocannabinoids and glutamate by a common molecular mechanism.

Mascia F, Klotz L, Lerch J, Ahmed MH, Zhang Y, Enz R.

J Neurochem. 2017 May;141(4):577-591. doi: 10.1111/jnc.14021. Epub 2017 Apr 12.

PMID:
28295323
10.

CB1 cannabinoid receptor activity is modulated by the cannabinoid receptor interacting protein CRIP 1a.

Niehaus JL, Liu Y, Wallis KT, Egertová M, Bhartur SG, Mukhopadhyay S, Shi S, He H, Selley DE, Howlett AC, Elphick MR, Lewis DL.

Mol Pharmacol. 2007 Dec;72(6):1557-66. Epub 2007 Sep 25.

11.

Opposite function of dopamine D1 and N-methyl-D-aspartate receptors in striatal cannabinoid-mediated signaling.

Daigle TL, Wetsel WC, Caron MG.

Eur J Neurosci. 2011 Nov;34(9):1378-89. doi: 10.1111/j.1460-9568.2011.07874.x.

13.

Striatal adenosine-cannabinoid receptor interactions in rats over-expressing adenosine A2A receptors.

Chiodi V, Ferrante A, Ferraro L, Potenza RL, Armida M, Beggiato S, Pèzzola A, Bader M, Fuxe K, Popoli P, Domenici MR.

J Neurochem. 2016 Mar;136(5):907-17. doi: 10.1111/jnc.13421. Epub 2015 Nov 24.

14.

The impact of adolescent social isolation on dopamine D2 and cannabinoid CB1 receptors in the adult rat prefrontal cortex.

Fitzgerald ML, Mackie K, Pickel VM.

Neuroscience. 2013 Apr 3;235:40-50. doi: 10.1016/j.neuroscience.2013.01.021. Epub 2013 Jan 16.

16.

The distinct role of medium spiny neurons and cholinergic interneurons in the D₂/A₂A receptor interaction in the striatum: implications for Parkinson's disease.

Tozzi A, de Iure A, Di Filippo M, Tantucci M, Costa C, Borsini F, Ghiglieri V, Giampà C, Fusco FR, Picconi B, Calabresi P.

J Neurosci. 2011 Feb 2;31(5):1850-62. doi: 10.1523/JNEUROSCI.4082-10.2011.

17.

Gene expression of opioid and dopamine systems in mouse striatum: effects of CB1 receptors, age and sex.

Gerald TM, Howlett AC, Ward GR, Ho C, Franklin SO.

Psychopharmacology (Berl). 2008 Jul;198(4):497-508. doi: 10.1007/s00213-008-1141-8. Epub 2008 Apr 27.

18.

Altered gene expression and functional activity of opioid receptors in the cerebellum of CB1 cannabinoid receptor knockout mice after acute treatments with cannabinoids.

Páldyová E, Bereczki E, Sántha M, Wenger T, Borsodi A, Benyhe S.

Acta Biol Hung. 2007;58 Suppl:113-29. doi: 10.1556/ABiol.58.2007.Suppl.9.

PMID:
18297798
19.

CB1 knockout mice display significant changes in striatal opioid peptide and D4 dopamine receptor gene expression.

Gerald TM, Ward GR, Howlett AC, Franklin SO.

Brain Res. 2006 Jun 6;1093(1):20-4. Epub 2006 May 8.

PMID:
16684513
20.

Antagonistic cannabinoid CB1/dopamine D2 receptor interactions in striatal CB1/D2 heteromers. A combined neurochemical and behavioral analysis.

Marcellino D, Carriba P, Filip M, Borgkvist A, Frankowska M, Bellido I, Tanganelli S, Müller CE, Fisone G, Lluis C, Agnati LF, Franco R, Fuxe K.

Neuropharmacology. 2008 Apr;54(5):815-23. doi: 10.1016/j.neuropharm.2007.12.011. Epub 2008 Jan 9.

PMID:
18262573

Supplemental Content

Support Center